08:57 AM EDT, 09/12/2024 (MT Newswires) -- Health care stocks were flat to higher premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was recently up 0.2%.

Fulcrum Therapeutics ( FULC ) shares tumbled by over 62% after the company said its phase 3 trial evaluating losmapimod in patients with facioscapulohumeral muscular dystrophy did not achieve its primary endpoint.